Efficacy and Safety of 3 Doses of S201086/GLPG1972 Administered Orally Once Daily in Patients with Knee Osteoarthritis. A 52-Week International, Multi-Regional, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study.

    Not Recruiting
Updated on 15 October 2021
knee pain


An investigational product administered orally for patients with osteoarthritis of the knee.


  • Three dose ranges of investigational product versus Placebo.
  • Patients can remain on their NSAID throughout the trial.
  • Details
    Condition Osteoarthritis
    Clinical Study IdentifierTX217835
    Last Modified on15 October 2021

    Similar trials to consider


    Browse trials for

    Not finding what you're looking for?

    Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

    Sign up as volunteer

    user name

    Added by • 



    Reply by • Private

    Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

      The passcode will expire in None.

    No annotations made yet

    Add a private note
    • abc Select a piece of text from the left.
    • Add notes visible only to you.
    • Send it to people through a passcode protected link.
    Add a private note